BioSpace News Archive

Apotex Inc. is recalling one lot of APO-Amitriptyline 10 mg tablets due to the presence of N-nitrosodimethylamine (NDMA), a nitrosamine impurity, above the acceptable limit.

Greenphire, the global leader in financial lifecycle management for clinical trials, today announced that Greenphire CEO, Jim Murphy, will participate in the panel session “The Critical Role of Planning and Budgeting for Patient Logistics,” and will be exhibiting at booth #406 during SCOPE Summit 2023 taking place February 6-9, 2023 in Orlando.

OneCause, a leading provider of digital fundraising technology, today announced the recipients of its Corporate Grants Program, committed to expanding access to technology and accelerating fundraising for emerging nonprofits and their missions.

Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will participate in a fireside chat at the SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023, at 3:00 p.m. ET / 12:00 p.m. PT.

Vesigen Therapeutics, Inc. today announced the expansion of the Scientific Advisory Board with the appointments of Connie Cepko, PhD and Kate Fitzgerald, PhD.

Stoke Therapeutics, Inc. today announced that management will present at the virtual SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023, at 4:20 p.m. ET.

Twist Bioscience Corporation today announced technology early access of the Twist enhanced Whole Genome Sequencing (eWGS) solution focused on non-human genomics applications, at the Advances in Genome Biology and Technology (AGBT) 2023 General Meeting in Hollywood, Florida.

TC Biopharm (Holdings) PLC today announced the official dosing of its final patient from the safety cohort for ACHIEVE, its phase 2B clinical trial of OmnImmune® (TCB008) for treatment of Acute Myeloid Leukemia (AML).

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch of the OncoExTra™ therapy selection test in the United States.

Carestream Health is partnering with Robarts Research Institute to increase and demonstrate the clinical value of digital X-ray, digital tomosynthesis and dual energy technologies to help improve the outcomes of patients with cardiothoracic and pulmonary diseases.